共 49 条
[1]
Guzzo M(1997)Salivary duct carcinoma: clinical characteristics and treatment strategies Head Neck 19 126-133
[2]
Di Palma S(2001)Salivary duct carcinoma: cytologic characteristics and application of androgen receptor immunostaining for diagnosis Cancer 93 344-350
[3]
Grandi C(1968)Salivary duct carcinoma: a group of salivary gland tumors analogous to mammary duct carcinoma Arch Klin Exp Ohren Nasen Kehlkopfheilkd 192 100-105
[4]
Molinari R(2010)Major and minor salivary gland tumors Crit Rev Oncol Hematol 74 134-148
[5]
Moriki T(2000)Expression of androgen receptor and prostatic specific markers in salivary duct carcinoma: an immunohistochemical analysis of 13 cases and review of the literature Am J Surg Pathol 24 579-586
[6]
Ueta S(2019)Adjuvant androgen deprivation therapy for poor-risk androgen receptor–positive salivary duct carcinoma Eur J Cancer 110 62-70
[7]
Takahashi T(2011)Androgen receptor-positive salivary duct carcinoma: a disease entity with promising new treatment options J Clin Oncol 29 e473-e476
[8]
Mitani M(2020)Salivary duct carcinoma: updates in histology, cytology, molecular biology, and treatment Cancer Cytopathol 128 693-703
[9]
Ichien M(2009)Androgen deprivation therapy: progress in understanding mechanisms of resistance and optimizing androgen depletion Nat Clin Pract Urol 6 76-85
[10]
Kleinsasser O(2017)Therapy-induced developmental reprogramming of prostate cancer cells and acquired therapy resistance Oncotarget 8 49-67